These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 16601540)

  • 1. Important determinants of bone strength: beyond bone mineral density.
    Friedman AW
    J Clin Rheumatol; 2006 Apr; 12(2):70-7. PubMed ID: 16601540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging concepts in osteoporosis and bone strength.
    Rubin CD
    Curr Med Res Opin; 2005 Jul; 21(7):1049-56. PubMed ID: 16004672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone strength and its determinants.
    Ammann P; Rizzoli R
    Osteoporos Int; 2003; 14 Suppl 3():S13-8. PubMed ID: 12730800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of bone mineral density, bone turnover, and other properties in reducing fracture risk during antiresorptive therapy.
    Epstein S
    Mayo Clin Proc; 2005 Mar; 80(3):379-88. PubMed ID: 15757020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture.
    Chesnut CH; Rosen CJ;
    J Bone Miner Res; 2001 Dec; 16(12):2163-72. PubMed ID: 11760829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of bone quality. Bone quality as the determinant of bone strength].
    Mori S
    Clin Calcium; 2008 Mar; 18(3):293-9. PubMed ID: 18310815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cortical bone and its microstructure in bone strength.
    Augat P; Schorlemmer S
    Age Ageing; 2006 Sep; 35 Suppl 2():ii27-ii31. PubMed ID: 16926200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical validation of surrogate endpoints: is bone density a valid surrogate for fracture?
    Li Z; Chines AA; Meredith MP
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):64-74. PubMed ID: 15615079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Change in the definition of osteoporosis especially on bone quality].
    Kishimoto H
    Clin Calcium; 2005 May; 15(5):736-40. PubMed ID: 15876733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase in bone mineral density and its effect on fracture risk].
    Sone T
    Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high bone turnover on the biomechanical properties of the L3 vertebra in an ovine model of early stage osteoporosis.
    Kennedy OD; Brennan O; Mahony NJ; Rackard SM; O'Brien FJ; Taylor D; Lee CT
    Spine (Phila Pa 1976); 2008 Nov; 33(23):2518-23. PubMed ID: 18978592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone metabolic marker; recent progress].
    Inaba M
    Clin Calcium; 2006 Jan; 16(1):74-80. PubMed ID: 16397354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of skeletal fragility.
    Bouxsein ML
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):897-911. PubMed ID: 16301186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineralization density distribution in health and disease.
    Roschger P; Paschalis EP; Fratzl P; Klaushofer K
    Bone; 2008 Mar; 42(3):456-66. PubMed ID: 18096457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PASSCLAIM - Bone health and osteoporosis.
    Prentice A; Bonjour JP; Branca F; Cooper C; Flynn A; Garabedian M; Müller D; Pannemans D; Weber P
    Eur J Nutr; 2003 Mar; 42 Suppl 1():I28-49. PubMed ID: 12664322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
    Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragility fractures in men with idiopathic osteoporosis are associated with undermineralization of the bone matrix without evidence of increased bone turnover.
    Fratzl-Zelman N; Roschger P; Misof BM; Nawrot-Wawrzyniak K; Pötter-Lang S; Muschitz C; Resch H; Klaushofer K; Zwettler E
    Calcif Tissue Int; 2011 May; 88(5):378-87. PubMed ID: 21318401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Osteoporosis: whom, when and how to treat?].
    Stepán J
    Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.